BRAF inhibitors enhance erythropoiesis and treat anemia through paradoxical activation of MAPK signaling.
Wu S, Deng Y, Sun H, Liu X, Zhou S, Zhao H, Li H, Guo F, Yue Q, Wu F, Zhao X, Li N, Zhu S, Hu Q, Xie S, Zheng J, Lv M, Kong Y, Huang XJ, Lei X, Tong X, Gao X, Lee HY.
Wu S, et al. Among authors: zhu s.
Signal Transduct Target Ther. 2024 Dec 2;9(1):338. doi: 10.1038/s41392-024-02033-6.
Signal Transduct Target Ther. 2024.
PMID: 39617757